Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma

We investigated the role of interleukin 8 (IL-8) in mediating angiogenesis in human bronchogenic carcinoma. Increased quantities of IL-8 were detected in tumor tissue as compared with normal lung tissue. Immunohistochemical staining of tumors revealed primary localization of IL-8 to individual tumor cells and demonstrated the capacity of tumor to elaborate IL-8. Functional studies that used tissue homogenates of tumors demonstrated the induction of both in vitro endothelial cell chemotaxis and in vivo corneal neovascularization. It is important to note that the addition of neutralizing antisera to IL-8 to these assays resulted in the marked and specific attenuation of these responses. Our observations definitively establish IL-8 as a primary mediator of angiogenesis in bronchogenic carcinoma and offer a potential target for immunotherapies against solid malignancies.

[1]  R. Whyte,et al.  The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma. , 1993, The American journal of pathology.

[2]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[3]  Erwin G. Van Meir,et al.  Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. , 1992, Cancer research.

[4]  Walter G. Gunn,et al.  American Cancer Society Textbook of Clinical Oncology , 1992 .

[5]  J. Falkenburg,et al.  Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure. , 1991, Lymphokine and cytokine research.

[6]  B. Dewald,et al.  Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8 , 1991, The Journal of experimental medicine.

[7]  A. Holleb,et al.  American Cancer Society textbook of clinical oncology , 1991 .

[8]  K. Matsushima,et al.  IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. , 1991, Immunology.

[9]  T. Standiford,et al.  Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. , 1990, The Journal of clinical investigation.

[10]  K. Suzuki,et al.  Coding region structure of interleukin-8 gene of human lung giant cell carcinoma LU65C cells that produce LUCT/interleukin-8: homogeneity in interleukin-8 genes. , 1990, Immunology letters.

[11]  R. Strieter,et al.  Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. , 1990, The American journal of pathology.

[12]  R. Strieter,et al.  Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. , 1990, Journal of immunology.

[13]  T. Standiford,et al.  Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta. , 1990, American journal of respiratory cell and molecular biology.

[14]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[15]  R. Strieter,et al.  Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. , 1989, The Journal of biological chemistry.

[16]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[17]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[18]  R. Strieter,et al.  Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. , 1989, Science.

[19]  J. Westwick,et al.  Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists. , 1989, Biochemical and biophysical research communications.

[20]  E. Appella,et al.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.

[21]  J. Schröder,et al.  Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). , 1988, Biochemical and biophysical research communications.

[22]  A. Koch,et al.  Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. , 1986, Arthritis and rheumatism.

[23]  J. Folkman.  Tumor angiogenesis. , 1985, Advances in cancer research.

[24]  B. Zetter,et al.  Migration of capillary endothelial cells is stimulated by tumour-derived factors , 1980, Nature.

[25]  P. Gullino,et al.  Acquisition of angiogenic capacity and neoplastic transformation in the rat mammary gland. , 1978, Cancer research.

[26]  E. Unanue,et al.  Activated macrophages induce vascular proliferation , 1977, Nature.

[27]  A. Fenselau,et al.  Growth stimulation of cultured endothelial cells by tumor cell homogenates. , 1976, Cancer research.

[28]  J. Folkman,et al.  Relation of vascular proliferation to tumor growth. , 1976, International review of experimental pathology.

[29]  '. AnneAtherton.  Growth Stimulation of Endothelial Cells by Simultaneous Culture with Sarcoma 180 Cells in Diffusion Chambers , 2022 .